New pill offers hope for severe Raynaud's sufferers

NCT ID NCT07112183

First seen Mar 27, 2026 · Last updated May 16, 2026 · Updated 6 times

Summary

This study tests an oral pill called treprostinil in 30 adults with severe Raynaud's phenomenon that hasn't improved with standard therapies. Raynaud's causes fingers and toes to change color and become painful in cold or stress due to narrowed blood vessels. Participants will take the pill three times daily for 26 weeks and track their daily symptoms to see if the treatment reduces attack frequency and severity.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for RAYNAUD PHENOMENA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Brigham and Women's Hospital

    NOT_YET_RECRUITING

    Boston, Massachusetts, 02115-6110, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Brigham and Women's Hospital

    RECRUITING

    Boston, Massachusetts, 02115, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.